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1 Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ ? ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x Tested and ƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƚŽ
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
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Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚnot be 
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
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Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
 
  
Version 2. 
Summary Vision Screening Data: Israel                                                             
vi 
 
2 Abbreviations 
ACT  Alternating Cover Test 
AR  Autorefraction 
AS  Automated Screening 
CT  Cover Test 
CV  Colour Vision 
EI Eye Inspection 
EM  Eye Motility 
Fix  Fixation 
GDP  Gross Domestic Product 
GP General Practitioner 
Hir  Hirschberg 
NICU Neonatal-intensive care unit 
NGOs Non-Governmental Organisations  
PM Pursuit Movements 
PPP  Purchasing Power Parity 
PPV Positive Predictive Value 
PR  Pupillary Reflexes 
RE  Retinal Examination 
ROP Retinopathy of Prematurity 
RR  Red Reflex Testing 
SV  Stereopsis 
VA  Visual Acuity  
WHO  World Health Organisation 
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3 Population and Healthcare Overview 
The population of Israel is 8,712,400 (World Bank, 2018a) and birth rate is estimated at 21.2 
births/1,000 population in 2016 (World Bank, 2018b). The change in population and birth 
rate from 1960 to 2017 is shown in Figure 1, graphs A and B respectively. 
Israel has a reported population density of 403 people per square kilometre in 2017 and this 
has risen from 101 people per square kilometre in 1961 (World Bank, 2018c). In terms of 
healthcare facilities, the total density of hospitals in 2013 was 0.56 per 100,000 population 
(WHO, 2016a). Infant mortality in 2017 is estimated at 2.9 deaths/1,000 live births in total 
(World Bank, 2018d). 
The average life expectancy in Israel is estimated at 82.4 years (World Bank, 2018e), with a 
death rate of 5.1 deaths/1,000 population in 2016 (World Bank, 2018f). Israel has a gross 
national income per capita (PPP int. $, 2013) of $32,000 (WHO, 2016b)  ? however, 
information provided by the country representative states that this is $40,272. The 
estimated total expenditure on health per capita in 2014) was $2,599 (Intl $) and the total 
expenditure on health in 2014 as percentage of GDP was 7.8% (WHO, 2016b). 
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Figure 1: Change in the Total Population and Birth Rate in Israel between 1960 and 2017 
 
Source: Information sourced from World Bank (2018) 
Version 2. 
Summary Vision Screening Data: Israel                                                                                              
 
3 
 
4. Vision Screening Commissioning and Guidance 
In Israel, vision screening is conducted either regionally or nationally depending on the age 
group and target condition. All regions provide some type of vision screening, but there are 
differences between protocols. Funding differs between regions and is provided through 
charity, health insurance, municipalities and the state.  
National vision screening is embedded into a general preventative child healthcare screening 
system. Decisions on what is provided are made with input from a professional advisory 
board. In the case of national screening there is also input from public health experts. The 
vision screening programme is only reviewed when a change is needed; any revisions are 
decided upon by the Public Health Service within the Israel Ministry of Health, based on 
discussions and expert opinion. Vision screening was implemented in 1983 and has changed 
since then; there has been update to the pass/fail criteria. 
Nationally organised vision screening consists of: 
භ In first grade there is nationally organised visual acuity screening.  
භ Developmental vision screening is nationally organised and funded by the government 
as general preventive childcare.  
 
Regionally organised screening consists of: 
භ There are regional initiatives by both non-governmental organisations (NGOs), such 
as the Lions Club, in collaboration with municipalities, as well as the two large 
municipalities who run preventive child services to provide vision screening.  
භ National red reflex screening in neonates is performed in all hospitals and paid for by 
National Insurance Institute; this pays for all birth related hospitalisations. 
භ Tel Aviv and Jerusalem municipalities that run preventive child care clinics have vision 
screening for amblyogenic risk factors in 2-year-old children. These are funded by the 
municipalities. 
භ Recently vision screening for amblyogenic risk factors in 2-year-old children that was 
provided in the Haifa sub-district was discontinued due to a lack of funding; this was 
originally funded by discretionary governmental funds. 
භ One health fund (Maccabi) provides ophthalmologic examinations for all 1-year-olds 
covered by their insurance.  
භ Two NGOs run photoscreening programs in 20 municipalities.  These are funded 
through a charity.  
භ The Ministry of Health funds vision screening for first grade children in schools 
delivered by optometrists. 
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Orthoptists, ophthalmologists, paediatricians, nurses, lay screeners and optometrists conduct 
vision screening. For the red reflex screen in the hospital, it is the paediatrician or paediatric 
resident who does the first and discharge neonatal exam. Public health nurses conduct 
behavioural screen in Well Child Clinics. Either public health nurses or optometrists conduct 
visual acuity screening in schools. In the Lions clubs, lay personnel conduct vision screening. 
It is not known how many there are per million population. Some nurses, optometrists, 
paediatricians do not screen but could do so with additional training; this is also true for 
general practitioners (GP) and family doctors. Currently, there is no specific or accredited 
course that provides training for vision screening professionals. 
Whilst there is information available on where and what programmes are implemented, there 
is no information regarding referral rates or outcomes. There are no methods for quality 
monitoring imposed by the government. There has been research conducted concerning the 
vision screening programme in Israel, specifically by Eibschitz-Tsimhoni et al. (2000) which 
was an evaluation of 1 to 2-year old vision screening for amblyogenic risk factors and Ore et 
al. (2009) which was an evaluation of the reliability of the E-chart as used with Israeli school 
children. There has been no cost-effectiveness analysis.  
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5. Screening programme  
The target conditions screened for by vision screening include cataract and other opacities at 
birth, reduced strabismus, visual acuity caused by either amblyopia or refractive error. The 
health care professionals delivering vision screening, venue for screening and tests used vary 
depending on the age of the child. Specific details of the screening offered within each age 
group are described more fully in sections 5.1 to 5.4 below. 
5.1 Vision screening - Preterm babies 
Preterm babies up to the age of 3 months are screened before discharge by an 
ophthalmologist in a neonatal intensive care unit (NICU) in a hospital. Preterm infants treated 
in NICU undergo an ROP exam.  Criteria are less than 32 gestational weeks or less than 1500 
grams birth weight, and they are examined at 6 weeks of age.  
5.2 Vision screening - Birth to 3 months 
Well, healthy babies up to the age of 3 months are screened by a paediatrician or a nurse in 
a hospital or a child healthcare centre. The tests conducted at this age include eye inspection, 
fixation, red reflex testing (paediatrician), eye motility and pursuit movement. Eye inspection 
and red reflex are conducted at the neonatal exam following birth. A developmental exam is 
conducted by nurses in well child clinics, this includes: fixation at 1 and 2 months of age, 
horizontal pursuit movements at 2 months. After one abnormal or one inconclusive test result 
babies are referred to an ophthalmologist if there is no red reflex or no fixation.  
5.3 Vision screening - 3 months to 36 months 
Children aged 3 to 36 months are screened by either an orthoptist or an optometrist in a child 
healthcare centre, nursery or kindergarten. The tests conducted include eye inspection, 
fixation, Hirschberg test and pursuit movements. After one abnormal or one inconclusive test 
result children are referred to an ophthalmologist if there is evidence of strabismus, or no 
following of a moving target.  
5.4 Vision screening - 36 months to 7 years 
Children aged between 36 months and 7 years are screened four times by a nurse, lay 
screener or an optometrist in a nursery, kindergarten, or school. The tests conducted at this 
age include visual acuity (VA), cover/uncover (in two municipalities) and automated screening 
(PlusOptix). Automated screening is conducted in some nursery schools (currently in 20 
municipalities) and kindergartens by lay screeners. In one small programme it is performed 
by optometrists.  School VA is performed by the school nurses or optometrists depending 
upon the provider and the geographic area. It is measured for the first time at 3 years of age, 
then repeated at ages 4 years, 6 years and 7 years. The optotype charts used to measure 
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visual acuity include Numbers and Tumbling E at child healthcare centres, and Snellen 
numbers in schools. These charts are Snellen based, linear format.  
Referral criteria at age 3 years are: 
භ VA less than 6/9 or 2-lines difference 
භ presence of strabismus 
 
Referral criteria at age 4 years is: 
භ VA less than 6/12.5 or 2-lines difference 
 
Referral criteria at age 6 are: 
භ VA of less than 6/9 or 2-lines difference 
භ presence of strabismus 
 
Referral criteria at age 7 years is: 
භ visual acuity less than 6/7.5 or 2-lines difference 
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Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1 Paediatrician Ophthalmologist Nurse Orthoptist Optometrist Layscreener 
Preterm babies  × 9 × × × × 
0 to 3 months  9 × 9 × × × 
3 to 36 months  × × × 9 9 × 
3 to 7 years  × × 9 × 9 9 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2 
RE EI RR 
Paediatrician 
EM Fix Hir CT 
2 regions 
PM VA AS 
20 
regions 
Preterm babies  9 × × × × × × × × × 
0 to 3 months  × 9 9 9 9 × × × × × 
3 to 36 months  × 9 × × 9 9 × 9 × × 
3 to 7 years  × × × × × × 9 × 9 9 
 
Key: RE: Retinal examination; EI: Eye inspection; RR: Red reflex testing; EM: Eye motility; Fix: Fixation; Hir: Hirschberg, CT: Cover/uncover test; 
PM: Pursuit movements; VA: Visual acuity; AS: Automated screening 
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Table 3: Location of vision screening for each age group  
Table 3 Hospital Child healthcare 
centre 
Nursery Kindergarten School 
Preterm babies  9 × × × × 
0 to 3 months  9 9 × × × 
3 to 36 months  × 9 9 9 × 
3 to 7 years  × × 9 9 9 
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6. Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error from 6 months of age. It provides objective results and is used to 
detect amblyopic risk factors. This differs from other methods used to screen children for 
amblyopia which focus on detection of the actual condition and the resulting visual loss.  
PlusOptix is used in Israel, the cost of these devices is approximately $10,000 (approximately 
8700 Euros, 19/11/2018). The maintenance costs per year and the number of years before 
the device is scheduled to be replaced are not known. 
A total of 20 municipalities are using automated screening. These are used to test children 
aged between 3-5 years of age in nursery schools. These are used as stand-alone tests, and 
are used on all children within these areas. Referral criteria are stated as:  
x PlusOptix:  
o Hypermetropia  of 3 Dioptres and above 
o Anisometropia of 0.75 Dioptres or above 
o Astigmatism of 1.5 Dioptres or above 
There is no comparative data between areas that use automated screening and areas that do 
not. 
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7. Provision for Visually Impaired  
In Israel, there are four special kindergartens and three special schools for blind or severely 
visually impaired children. It is not known exactly how many children attend these schools. 
The costs per child for these schools are not available. There is special support for visually 
impaired children who attend regular mainstream primary school, the Ministry of Health 
subsidises rehabilitative devices: telescopic and microscope glasses, contact lenses and scleral 
lenses for children who cannot benefit from regular prescription glasses. The subsidy consists 
of 75% of the cost of the devices (parents who are below a certain income are not required 
to pay); children who gain 3 lines of vision beyond the visual acuity achieved with regular 
prescription lenses are eligible for this benefit. There are also special supplementary teachers 
for support in mainstream school. 
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8. Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
There is no data available concerning the prevalence of treated or untreated amblyopia at the 
age of 7 years. However, a study by Morad et al. (2007) found that at 16 years of age it is 
0.98% irrespective of whether or not the individual had been screened or not. This study also 
found that in a sample of 260,186 Israelis, the prevalence of:  
Ɣ ŶŝƐŽŵĞƚƌŽƉŝĂA? ?ƐƉŚĞƌĞĂŶĚ ?ŽƌĐǇůŝŶĚĞƌA? ? ?,226 (6.3%) 
Ɣ Strabismus = 2,321 (0.89%) 
Ɣ Strabismus and anisometropia = 442 (0.16%) 
Ɣ ŝůĂƚĞƌĂůŵǇŽƉŝĂA? ?A? ? ? ? ? ? ? ? ? ? ?A? ? 
Ɣ ŝůĂƚĞƌĂůŚǇƉĞƌŽƉŝĂA? ?A? ? ? ? ? ? ? ? ?A? ? 
Ɣ ŝůĂƚĞƌĂůĂƐƚŝŐŵĂƚŝƐŵA? ?A? ? ? ? ? ? ? ? ? ? ?A? ? 
Ɣ Cataract 233 (0.09%)  
Ɣ Ptosis 125 (0.05%) 
 
The prevalence of strabismus was similarly reported as 0.6% at age 17 years (Shapira et al., 
2016). These results are based on a population of 107,608 young adults born between 1971 
and 1994 from a computerised database of the northern recruitment centre of Israel.  
8.2 Coverage 
All neonates born in a hospital are screened. In the first year of life 95% of infants attend 
preventative child clinics and receive behavioural visual screening. Approximately 50% of the 
children invited to the visual screening for toddlers (questionnaires, cover/uncover test, rapid 
manual retinoscopy) in the cities of Tel Aviv and Jerusalem attend. Public health nurses send 
invitation letters, appointments can also be self-initiated. In summary coverage rates are: 
Ɣ At birth - Red reflex in hospital: approximately 99% 
Ɣ First year of life - Behavioural vision screen in preventive care clinics:  approximately 
95% 
Ɣ Age 3 to 5 years - VA screen: reported to be very low, no actual data available.  
Ɣ First grade (6 years of age) - Visual acuity screen:  97% 
 
In a 2014 audit of national data from hospital neonatal discharge records, it was found that 
at discharge after birth:  
Ɣ 0.16/1000 live births - congenital cataract 
Ɣ 0.02/1000 live births - congenital glaucoma 
Ɣ 0.01/1000 live births  ? anophthalmia 
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8.3 Screening evaluation 
There is no data available concerning the percentage of false positive, false negative, the 
positive predictive value (PPV), sensitivity or specificity of screening in Israel. Professional 
estimates are 1/150 (0.67%) false negatives, 1/150 (0.67%) false positives and 70% PPV for 
first grade age children. 
8.4 Treatment success 
There is no information available concerning the percentage of children treated for 
strabismus or amblyopia before the age of 7 years, or the percentage of compliance with a 
referral after an abnormal screening test result. However, as with neonatal hearing screening, 
abnormal red reflex is noted in the neonatal discharge along with the referral and the result 
of the screening, this is a routine part of the admission questions to preventative care clinics.  
The number of patients treated for congenital cataract or strabismus each year is not known.  
Ophthalmologists are the only professionals that provide glasses for children under the age 
of 7 years. Other treatment options include patching, penalisation with glasses, atropine and 
cataract surgery. All are offered treatment , and the National Health Insurance covers the cost 
all treatment. However, there are issues of compliance, and to a less degree accessibility in 
terms of the lengthy waiting times for ophthalmologists in certain rural areas. 
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9. Costs of vision screening in children 
9.1 Cost of vision screening  
No data is available cornering the salary per year for each professional for vision screening, 
the costs to train vision screening professionals, the total screening costs per year for vision 
screening, or the total costs per child per year for vision screening.  
9.2 Cost of treatment for amblyopia 
The estimated costs for treatment of typical patients, with refractive amblyopia and 
strabismic amblyopia including follow-up:  
Ɣ 6 clinic visits at 50 Euros each =300 Euros 
Ɣ Glasses = 150 Euros  
Ɣ Strabismus surgery = 1000 Euros 
9.3 Cost of Treatment for strabismus  
 The estimated costs for strabismus surgery including follow-up: 
Ɣ Surgery = 1000 Euro 
Ɣ 6 Visits = 300 Euro 
9.4 Cost of treatment for cataract 
The estimated costs for congenital cataract surgery including follow-up of deprivation 
amblyopia:  
Ɣ 20 visits = 1000 Euros 
Ɣ Glasses = 250 Euros (bifocal) 
Ɣ Surgery = 1500 Euro 
Ɣ Contact lenses = 1000 Euro 
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